 reported incidence of at least 2 documented episodes of symptomatic AF paroxysmal, persistent or long standing persistent during the 3 months preceding the initial AF ablation attempt of at least one Class I or III anti-arrhythmia drug with failure defined as recurrence of symptomatic AF or adverse drug effect resulting in stopping medication 